ABBV · News · 20261102N
Guidance / Outlook
AbbVie Inc. · 2026-11-02 · Importance 51 · Surprise 60 · In source text
AbbVie raised its 2026 revenue outlook by $200 million to approximately $67.8 billion. The company set adjusted EPS guidance at $13.95–$13.99 per share, with a midpoint of $13.97. Fourth-quarter 2026 revenue was projected at approximately $18.4 billion, with adjusted EPS of $3.83–$3.87 per share.
Key facts
- AbbVie raised adjusted earnings guidance to $13.95-$13.99 per share and projected fourth-quarter revenues of approximately $18.4 billion and adjusted earnings of $3.83-$3.87 per share. source
- AbbVie raised its 2026 revenue expectation by $200 million to approximately $67.8 billion. source
- AbbVie reiterated full-year adjusted EPS guidance of $13.97 at the midpoint. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | +1.0% | AbbVie raised its 2026 revenue expectation by $200 million to approximately $67.8 billion. |
| revenue | unclear | committed | — | AbbVie raised adjusted earnings guidance to $13.95-$13.99 per share and projected fourth-quarter revenues of approximately $18.4 billion… |
| net_income | positive | committed | — | AbbVie raised adjusted earnings guidance to $13.95-$13.99 per share and projected fourth-quarter revenues of approximately $18.4 billion… |
| net_income | unclear | committed | — | AbbVie raised adjusted earnings guidance to $13.95-$13.99 per share and projected fourth-quarter revenues of approximately $18.4 billion… |